Exponent Crushes Q2 Estimates, Raises Full-Year Outlook, and Boosts Buyback by $50M
EXPO sits 28% above its 52-week low of $51.91.
Summary
Exponent reported Q2 2026 results well above expectations, raised full-year guidance, and authorized an additional $50M for share buybacks alongside its regular dividend.
Key Events · Earnings and Guidance · EXPO
-
Q2 Revenue and Earnings Beat
Revenues before reimbursements rose 12% to $148.9M, net income reached $29.4M ($0.60 diluted EPS), and the EBITDA margin expanded to 28.7%.
-
Full-Year Guidance Raised
Management now expects revenues before reimbursements to grow 9–10% and an EBITDA margin of 27.8–28.1%, up from prior implied ranges.
-
Buyback Authorization Increased by $50M
The Board approved an additional $50M for share repurchases, adding to the existing program; $146.1M was already repurchased in H1 2026.
-
Quarterly Dividend Maintained
A $0.31 per share dividend was declared, payable September 18, 2026, continuing the company's track record of returning cash to shareholders.
Analysis · EXPO · Trade & Services
A standout quarter saw revenue of $171.6M beat consensus by over 16% and net income jump to $29.4M. Confidence in sustained demand for AI-related and infrastructure consulting drove management to raise full-year revenue growth guidance to 9–10% and the EBITDA margin to 27.8–28.1%. Even with the stock trading near all-time highs, a $50M increase in the share repurchase program and a steady $0.31 dividend underscore a commitment to returning capital. The combination of strong execution, raised guidance, and enhanced shareholder returns makes this a significant positive event.
At the time of this filing, EXPO was trading at $66.68 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $51.91 to $81.95. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.